THERAVANCE BIOPHARMA INC

CUSIP: 88339KAA0 Class: NOTE

Calamos Advisors LLC's Holding History (CIK: 0001316507)

Note: Option positions (PUT/CALL) are excluded.

Q3 2020
Shares 2,500,000 Value ($000) $2,207 Avg Close — Range —
Q2 2020
Shares 5,000,000 Value ($000) $4,859 Avg Close — Range —
Q1 2020
Shares 5,000,000 Value ($000) $4,879 Avg Close — Range —
Q4 2019
Shares 5,000,000 Value ($000) $5,205 Avg Close — Range —
Q3 2019
Shares 5,000,000 Value ($000) $4,628 Avg Close — Range —
Q2 2019
Shares 5,000,000 Value ($000) $4,337 Avg Close — Range —
Q1 2019
Shares 5,000,000 Value ($000) $4,855 Avg Close — Range —
Q4 2018
Shares 5,000,000 Value ($000) $5,157 Avg Close — Range —
Q3 2018
Shares 5,000,000 Value ($000) $5,972 Avg Close — Range —
Q2 2018
Shares 5,000,000 Value ($000) $4,966 Avg Close — Range —